Vicapsys Life Sciences, Inc.
VICP
SEC CIK 1468639
Follow Vicapsys Life Sciences
Weekly email: filings, results, news
Net income
−$235.5K
+2% vs same quarter last year
EPS, diluted
−$0.01
+0% vs same quarter last year
Operating cash flow
−$40.4K
+62.4% vs same quarter last year
Operating income
−$198.9K
−13.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY23 | −$1.2M |
| FY22 | −$984.8K |
| FY21 | −$236.9K |
| FY20 | −$765.8K |
| FY19 | −$1.4M |
| FY18 | - |
News
No stories filed under Vicapsys Life Sciences yet - coverage appears here as the news feed clusters it.